Contact
searchSearch
HMP Global

Ulcerative Colitis Topic Center

Featured Content

IBD Drive time logo
Podcast
IBD Drive Time: Frank Scott, MD, on the AGA Guidelines for Ulcerative Colitis Management
12/30/2024
In this IBD Drive Time podcast, Dr Frank Scott from the University of Colorado and host Dr Raymond Cross discuss updates in the AGA guidelines for ulcerative colitis.
In this IBD Drive Time podcast, Dr Frank Scott from the University of Colorado and host Dr Raymond Cross discuss updates in the AGA guidelines for ulcerative colitis.
In this IBD Drive Time podcast,...
12/30/2024
Advances in Inflammatory Bowel Disease Network
Maia Kayal
Video
Maia Kayal MD, on Strategies for Managing Patients When Mesalamine Fails
12/27/2024
Dr Kayal reviews the options available when patients with ulcerative colitis do not respond or lose response to mesalamine therapy, and the considerations of patient factors, patient preferences, and safety that should be taken into account.
Dr Kayal reviews the options available when patients with ulcerative colitis do not respond or lose response to mesalamine therapy, and the considerations of patient factors, patient preferences, and safety that should be taken into account.
Dr Kayal reviews the options...
12/27/2024
Advances in Inflammatory Bowel Disease Network
Poll
Poll: Treating Acute Severe Ulcerative Colitis
12/17/2024
With many recently approved therapies for ulcerative colitis available today, which do you turn to first for patients hospitalized for acute severe ulcerative colitis? Let us know in our poll!
With many recently approved therapies for ulcerative colitis available today, which do you turn to first for patients hospitalized for acute severe ulcerative colitis? Let us know in our poll!
With many recently approved...
12/17/2024
Advances in Inflammatory Bowel Disease Network
Millie Long
Conference coverage
Millie Long, MD, on Defining Disease Severity in Ulcerative Colitis
12/16/2024
Dr Millie Long discusses the difference between the "snapshot" of disease activity and the "movie" of disease severity, and the importance of carefully assessing severity when choosing therapies and developing monitoring strategies for...
Dr Millie Long discusses the difference between the "snapshot" of disease activity and the "movie" of disease severity, and the importance of carefully assessing severity when choosing therapies and developing monitoring strategies for...
Dr Millie Long discusses the...
12/16/2024
Advances in Inflammatory Bowel Disease Network
Conference Coverage
Subcutaneous Mirikizumab Found Tolerable After Hypersensitivity Reaction to IV Infusion
12/10/2024
A case study published in The American Journal of Gastroenterology presented at Advances in Inflammatory Bowel Diseases (AIBD), highlights a successful rechallenge with subcutaneous mirikizumab.
A case study published in The American Journal of Gastroenterology presented at Advances in Inflammatory Bowel Diseases (AIBD), highlights a successful rechallenge with subcutaneous mirikizumab.
A case study published in The...
12/10/2024
Advances in Inflammatory Bowel Disease Network
Video
Maria Abreu, MD, on When the First Advanced Therapy Fails in UC
12/09/2024
What do you do when a first advanced therapy fails to control ulcerative colitis? Dr Abreu reviews her presentation from the Advances in IBD conference on how choose the next option among the many therapies available now.
What do you do when a first advanced therapy fails to control ulcerative colitis? Dr Abreu reviews her presentation from the Advances in IBD conference on how choose the next option among the many therapies available now.
What do you do when a first...
12/09/2024
Advances in Inflammatory Bowel Disease Network
Corey Siegel
Video
Corey Siegel, MD, on Shared Decision-Making in Ulcerative Colitis
12/06/2024
Dr Siegel, from Dartmouth-Hitchcock Medical Center in New Hampshire, reviews the importance of shared decision-making, careful listening, and providing guidance in developing treatment plans for patients with ulcerative colitis.
Dr Siegel, from Dartmouth-Hitchcock Medical Center in New Hampshire, reviews the importance of shared decision-making, careful listening, and providing guidance in developing treatment plans for patients with ulcerative colitis.
Dr Siegel, from...
12/06/2024
Advances in Inflammatory Bowel Disease Network
News
Real-World Results of First-Line Advanced Therapies for Ulcerative Proctitis
12/05/2024
This retrospective cohort study, presented at the American College of Gastroenterology scientific meeting, examined the effectiveness of advanced therapies in bionaïve patients with ulcerative proctitis.
This retrospective cohort study, presented at the American College of Gastroenterology scientific meeting, examined the effectiveness of advanced therapies in bionaïve patients with ulcerative proctitis.
This retrospective cohort study,...
12/05/2024
Advances in Inflammatory Bowel Disease Network
News
Advanced Therapies for Patients With Severe Ulcerative Colitis
12/05/2024
A new study compares the efficacy of advanced therapies with corticosteroids in hospitalized patients with acute severe ulcerative colitis as first- and second-line therapies.
A new study compares the efficacy of advanced therapies with corticosteroids in hospitalized patients with acute severe ulcerative colitis as first- and second-line therapies.
A new study compares the...
12/05/2024
Advances in Inflammatory Bowel Disease Network
News
Intestinal Ultrasound Predicts Response to Therapy in Ulcerative Colitis
11/26/2024
Intestinal ultrasound served as a surrogate for endoscopy in predicting drug-specific response within 6 weeks among patients with ulcerative colitis.
Intestinal ultrasound served as a surrogate for endoscopy in predicting drug-specific response within 6 weeks among patients with ulcerative colitis.
Intestinal ultrasound served as...
11/26/2024
Advances in Inflammatory Bowel Disease Network
News
Specific Factors Predict Rescue Therapy Response in Acute Severe Ulcerative Colitis
11/22/2024
More than 3 dozen factors are associated with response to rescue therapy in patients with acute severe ulcerative colitis, according to a systematic review.
More than 3 dozen factors are associated with response to rescue therapy in patients with acute severe ulcerative colitis, according to a systematic review.
More than 3 dozen factors are...
11/22/2024
Advances in Inflammatory Bowel Disease Network

News

News
Real-World Results of First-Line Advanced Therapies for Ulcerative Proctitis
12/05/2024
This retrospective cohort study, presented at the American College of Gastroenterology scientific meeting, examined the effectiveness of advanced therapies in bionaïve patients with ulcerative proctitis.
This retrospective cohort study, presented at the American College of Gastroenterology scientific meeting, examined the effectiveness of advanced therapies in bionaïve patients with ulcerative proctitis.
This retrospective cohort study,...
12/05/2024
Advances in Inflammatory Bowel Disease Network
News
Advanced Therapies for Patients With Severe Ulcerative Colitis
12/05/2024
A new study compares the efficacy of advanced therapies with corticosteroids in hospitalized patients with acute severe ulcerative colitis as first- and second-line therapies.
A new study compares the efficacy of advanced therapies with corticosteroids in hospitalized patients with acute severe ulcerative colitis as first- and second-line therapies.
A new study compares the...
12/05/2024
Advances in Inflammatory Bowel Disease Network
News
Intestinal Ultrasound Predicts Response to Therapy in Ulcerative Colitis
11/26/2024
Intestinal ultrasound served as a surrogate for endoscopy in predicting drug-specific response within 6 weeks among patients with ulcerative colitis.
Intestinal ultrasound served as a surrogate for endoscopy in predicting drug-specific response within 6 weeks among patients with ulcerative colitis.
Intestinal ultrasound served as...
11/26/2024
Advances in Inflammatory Bowel Disease Network
News
Specific Factors Predict Rescue Therapy Response in Acute Severe Ulcerative Colitis
11/22/2024
More than 3 dozen factors are associated with response to rescue therapy in patients with acute severe ulcerative colitis, according to a systematic review.
More than 3 dozen factors are associated with response to rescue therapy in patients with acute severe ulcerative colitis, according to a systematic review.
More than 3 dozen factors are...
11/22/2024
Advances in Inflammatory Bowel Disease Network
News
Impact of Concomitant Medications on Advanced Therapies for Ulcerative Colitis
11/12/2024
Most concomitant medications do not affect the efficacy or safety of advanced therapies in ulcerative colitis clinical trials, according to a recent study.
Most concomitant medications do not affect the efficacy or safety of advanced therapies in ulcerative colitis clinical trials, according to a recent study.
Most concomitant medications do...
11/12/2024
Advances in Inflammatory Bowel Disease Network
Research Highlights
Colectomy Associated With Risk of Kidney Failure
11/09/2024
Patients undergoing colectomy may benefit from enhanced kidney function monitoring, surveillance, and timely referral to nephrology care.
Patients undergoing colectomy may benefit from enhanced kidney function monitoring, surveillance, and timely referral to nephrology care.
Patients undergoing colectomy...
11/09/2024
Advances in Inflammatory Bowel Disease Network
News
Standard Dosing of Infliximab Effective for Steroid-Refractory ASUC
10/18/2024
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
Scores Predict Corticosteroid Failure Risk in Patients With ASUC
10/03/2024
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that...
10/03/2024
Advances in Inflammatory Bowel Disease Network
FDA alert
FDA Alert
FDA Approves Guselkumab for Moderate to Severe Ulcerative Colitis
09/12/2024
Johnson & Johnson’s guselkumab is the first and only fully-human, dual-acting monoclonal antibody that blocks IL-23 and binds to CD64.
Johnson & Johnson’s guselkumab is the first and only fully-human, dual-acting monoclonal antibody that blocks IL-23 and binds to CD64.
Johnson & Johnson’s guselkumab...
09/12/2024
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib vs Tofacitinib for Clinical Remission in Ulcerative Colitis
08/09/2024
Investigators conducted a head-to-head trial of the 2 JAK inhibitors to determine which performed best in achieving steroid-free clinical remission among patients with ulcerative colitis
Investigators conducted a head-to-head trial of the 2 JAK inhibitors to determine which performed best in achieving steroid-free clinical remission among patients with ulcerative colitis
Investigators conducted a...
08/09/2024
Advances in Inflammatory Bowel Disease Network
News
FDA Expands Approval of Mirikizumab to Crohn's Disease 
01/16/2025
Among those who achieved clinical remission and endoscopic response at one year, nearly 90% of patients maintained clinical remission with 2 years of continuous treatment with mirikizumab in open-label extension
Among those who achieved clinical remission and endoscopic response at one year, nearly 90% of patients maintained clinical remission with 2 years of continuous treatment with mirikizumab in open-label extension
Among those who achieved...
01/16/2025
Advances in Inflammatory Bowel Disease Network
News
Stem Cell Therapy Shows Promise for Medically Refractory Crohn’s Disease
12/16/2024
In a systematic review, stem cell therapy demonstrated a significant advantage over placebo or no treatment in achieving clinical remission among patients with refractory Crohn's disease.
In a systematic review, stem cell therapy demonstrated a significant advantage over placebo or no treatment in achieving clinical remission among patients with refractory Crohn's disease.
In a systematic review, stem...
12/16/2024
Advances in Inflammatory Bowel Disease Network
News
Study Highlights Effectiveness of Medical Therapies for Fistulizing Crohn’s Disease
12/13/2024
A systematic review assessing pharmacologic therapies for fistulizing Crohn’s disease (CD), has provided insights into their efficacy.
A systematic review assessing pharmacologic therapies for fistulizing Crohn’s disease (CD), has provided insights into their efficacy.
A systematic review assessing...
12/13/2024
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Effective for Crohn’s Disease Regardless of Prior Biologic Failure
12/06/2024
The Janus kinase inhibitor showed definite superiority over placebo in inducing and maintaining clinical remission and endoscopic response among patients who did not respond or lost response to biologic therapies for Crohn’s disease.
The Janus kinase inhibitor showed definite superiority over placebo in inducing and maintaining clinical remission and endoscopic response among patients who did not respond or lost response to biologic therapies for Crohn’s disease.
The Janus kinase inhibitor...
12/06/2024
Advances in Inflammatory Bowel Disease Network
News
MRI and Blood Biomarkers Predict Surgery Risk in Ileal Crohn’s Disease
12/05/2024
A new study highlights the predictive power of MRI metrics and circulating biomarkers in determining surgical needs for children and adults with Crohn’s disease.
A new study highlights the predictive power of MRI metrics and circulating biomarkers in determining surgical needs for children and adults with Crohn’s disease.
A new study highlights the...
12/05/2024
Advances in Inflammatory Bowel Disease Network
News
Extraintestinal Risks in IBD: Who’s Most Vulnerable?
12/05/2024
A large cohort study reveals key factors linked to multiple extraintestinal manifestations in inflammatory bowel disease, offering new insights into personalized treatment approaches.
A large cohort study reveals key factors linked to multiple extraintestinal manifestations in inflammatory bowel disease, offering new insights into personalized treatment approaches.
A large cohort study reveals key...
12/05/2024
Advances in Inflammatory Bowel Disease Network
News
Real-World Results of First-Line Advanced Therapies for Ulcerative Proctitis
12/05/2024
This retrospective cohort study, presented at the American College of Gastroenterology scientific meeting, examined the effectiveness of advanced therapies in bionaïve patients with ulcerative proctitis.
This retrospective cohort study, presented at the American College of Gastroenterology scientific meeting, examined the effectiveness of advanced therapies in bionaïve patients with ulcerative proctitis.
This retrospective cohort study,...
12/05/2024
Advances in Inflammatory Bowel Disease Network
News
Advanced Therapies for Patients With Severe Ulcerative Colitis
12/05/2024
A new study compares the efficacy of advanced therapies with corticosteroids in hospitalized patients with acute severe ulcerative colitis as first- and second-line therapies.
A new study compares the efficacy of advanced therapies with corticosteroids in hospitalized patients with acute severe ulcerative colitis as first- and second-line therapies.
A new study compares the...
12/05/2024
Advances in Inflammatory Bowel Disease Network
News
AI Breakthrough in Crohn’s Disease: Automated Imaging Enhances Diagnosis
12/04/2024
A new deep learning model accurately identifies Crohn’s disease lesions and assesses disease activity, offering radiologists a powerful tool for precision care.
A new deep learning model accurately identifies Crohn’s disease lesions and assesses disease activity, offering radiologists a powerful tool for precision care.
A new deep learning model...
12/04/2024
Advances in Inflammatory Bowel Disease Network
News
Intestinal Ultrasound Predicts Response to Therapy in Ulcerative Colitis
11/26/2024
Intestinal ultrasound served as a surrogate for endoscopy in predicting drug-specific response within 6 weeks among patients with ulcerative colitis.
Intestinal ultrasound served as a surrogate for endoscopy in predicting drug-specific response within 6 weeks among patients with ulcerative colitis.
Intestinal ultrasound served as...
11/26/2024
Advances in Inflammatory Bowel Disease Network

Insights

IBD Drive time logo
Podcast
IBD Drive Time: Frank Scott, MD, on the AGA Guidelines for Ulcerative Colitis Management
12/30/2024
In this IBD Drive Time podcast, Dr Frank Scott from the University of Colorado and host Dr Raymond Cross discuss updates in the AGA guidelines for ulcerative colitis.
In this IBD Drive Time podcast, Dr Frank Scott from the University of Colorado and host Dr Raymond Cross discuss updates in the AGA guidelines for ulcerative colitis.
In this IBD Drive Time podcast,...
12/30/2024
Advances in Inflammatory Bowel Disease Network
Maia Kayal
Video
Maia Kayal MD, on Strategies for Managing Patients When Mesalamine Fails
12/27/2024
Dr Kayal reviews the options available when patients with ulcerative colitis do not respond or lose response to mesalamine therapy, and the considerations of patient factors, patient preferences, and safety that should be taken into account.
Dr Kayal reviews the options available when patients with ulcerative colitis do not respond or lose response to mesalamine therapy, and the considerations of patient factors, patient preferences, and safety that should be taken into account.
Dr Kayal reviews the options...
12/27/2024
Advances in Inflammatory Bowel Disease Network
Video
Maria Abreu, MD, on When the First Advanced Therapy Fails in UC
12/09/2024
What do you do when a first advanced therapy fails to control ulcerative colitis? Dr Abreu reviews her presentation from the Advances in IBD conference on how choose the next option among the many therapies available now.
What do you do when a first advanced therapy fails to control ulcerative colitis? Dr Abreu reviews her presentation from the Advances in IBD conference on how choose the next option among the many therapies available now.
What do you do when a first...
12/09/2024
Advances in Inflammatory Bowel Disease Network
Corey Siegel
Video
Corey Siegel, MD, on Shared Decision-Making in Ulcerative Colitis
12/06/2024
Dr Siegel, from Dartmouth-Hitchcock Medical Center in New Hampshire, reviews the importance of shared decision-making, careful listening, and providing guidance in developing treatment plans for patients with ulcerative colitis.
Dr Siegel, from Dartmouth-Hitchcock Medical Center in New Hampshire, reviews the importance of shared decision-making, careful listening, and providing guidance in developing treatment plans for patients with ulcerative colitis.
Dr Siegel, from...
12/06/2024
Advances in Inflammatory Bowel Disease Network
Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
10/21/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
10/21/2024
Advances in Inflammatory Bowel Disease Network
David Rubin
Video
David Rubin, MD, on the QUASAR Maintenance Study of Guselkumab
10/15/2024
Dr Rubin discusses the results of the maintenance component of the QUASAR study of guselkumab, an IL-23/p19 inhibitor, in the treatment of ulcerative colitis, which he presented at Digestive Disease Week.
Dr Rubin discusses the results of the maintenance component of the QUASAR study of guselkumab, an IL-23/p19 inhibitor, in the treatment of ulcerative colitis, which he presented at Digestive Disease Week.
Dr Rubin discusses the results...
10/15/2024
Advances in Inflammatory Bowel Disease Network
Phillip Gu
Video
Phillip Gu, MD, on Acute Severe Ulcerative Colitis
09/07/2024
Dr Gu recaps his talk from the Los Angeles regional meeting on the most critical factors in caring for patients with acute severe ulcerative colitis, including testing for C difficile, involving the surgeon early, and ensuring patients...
Dr Gu recaps his talk from the Los Angeles regional meeting on the most critical factors in caring for patients with acute severe ulcerative colitis, including testing for C difficile, involving the surgeon early, and ensuring patients...
Dr Gu recaps his talk from the...
09/07/2024
Advances in Inflammatory Bowel Disease Network
Gil Y. Melmed, MD
Video
Gil Melmed, MD, on Comparative Effectiveness in Ulcerative Colitis
09/07/2024
Dr Melmed reviews his presentation from the AIBD regional meeting in Los Angeles on using dat
Dr Melmed reviews his presentation from the AIBD regional meeting in Los Angeles on using dat
Dr Melmed reviews his...
09/07/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Erin Forster, MD, on Risankizumab for Ulcerative Colitis
09/03/2024
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical...
09/03/2024
Advances in Inflammatory Bowel Disease Network
Ed Barnes
Video
Edward Barnes, MD, on Updates in Ulcerative Colitis
07/17/2024
Dr Barnes provides updates on advances in the treatment of ulcerative colitis, including new therapies approved and how those therapies could change clinical practice.
Dr Barnes provides updates on advances in the treatment of ulcerative colitis, including new therapies approved and how those therapies could change clinical practice.
Dr Barnes provides updates on...
07/17/2024
Advances in Inflammatory Bowel Disease Network
Marla Dubinsky
Conference coverage
Marla Dubinsky, MD, on Risk Stratification in Crohn's Disease
01/16/2025
Dr Dubinsky opened the 2024 Advances in Inflammatory Bowel Disease conference with a firm statement that virtually all patients with Crohn's disease should be treated quickly after diagnosis with approved and effective therapies to help...
Dr Dubinsky opened the 2024 Advances in Inflammatory Bowel Disease conference with a firm statement that virtually all patients with Crohn's disease should be treated quickly after diagnosis with approved and effective therapies to help...
Dr Dubinsky opened the 2024...
01/16/2025
Advances in Inflammatory Bowel Disease Network
Ed Loftus
Video
Edward Loftus, MD, on Upper GI Crohn's Disease
01/07/2025
Dr Loftus explains how Crohn's disease can affect the upper gastrointestinal system, from the mouth to the duodenum, and the options for treating this rare presentation.
Dr Loftus explains how Crohn's disease can affect the upper gastrointestinal system, from the mouth to the duodenum, and the options for treating this rare presentation.
Dr Loftus explains how Crohn's...
01/07/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Frank Scott, MD, on the AGA Guidelines for Ulcerative Colitis Management
12/30/2024
In this IBD Drive Time podcast, Dr Frank Scott from the University of Colorado and host Dr Raymond Cross discuss updates in the AGA guidelines for ulcerative colitis.
In this IBD Drive Time podcast, Dr Frank Scott from the University of Colorado and host Dr Raymond Cross discuss updates in the AGA guidelines for ulcerative colitis.
In this IBD Drive Time podcast,...
12/30/2024
Advances in Inflammatory Bowel Disease Network
Maia Kayal
Video
Maia Kayal MD, on Strategies for Managing Patients When Mesalamine Fails
12/27/2024
Dr Kayal reviews the options available when patients with ulcerative colitis do not respond or lose response to mesalamine therapy, and the considerations of patient factors, patient preferences, and safety that should be taken into account.
Dr Kayal reviews the options available when patients with ulcerative colitis do not respond or lose response to mesalamine therapy, and the considerations of patient factors, patient preferences, and safety that should be taken into account.
Dr Kayal reviews the options...
12/27/2024
Advances in Inflammatory Bowel Disease Network
Millie Long
Video
Millie Long, MD: The Sherman Prize 2024
12/25/2024
Dr Long, one of the winners of the 2024 Sherman Prize, discusses the importance of the prize in helping to move the field of IBD research and treatment forward.
Dr Long, one of the winners of the 2024 Sherman Prize, discusses the importance of the prize in helping to move the field of IBD research and treatment forward.
Dr Long, one of the winners of...
12/25/2024
Advances in Inflammatory Bowel Disease Network
Dermot McGovern
Video
Dermot McGovern, MD: Sherman Prize 2024
12/25/2024
Dr McGovern, one of the winners of the 2024 Sherman Prize, reviews the work of his group at Cedars-Sinai in the genetics of IBD and their efforts to clarify the heterogeneity of ulcerative colitis and Crohn's disease.
Dr McGovern, one of the winners of the 2024 Sherman Prize, reviews the work of his group at Cedars-Sinai in the genetics of IBD and their efforts to clarify the heterogeneity of ulcerative colitis and Crohn's disease.
Dr McGovern, one of the winners...
12/25/2024
Advances in Inflammatory Bowel Disease Network
Jordan Axelrad
Video
Jordan Axelrad, MD: The Sherman Emerging Leader Prize 2024
12/25/2024
Dr Axelrad has become a leader in the area of malignancy among patients with IBD, which was recognized with the Sherman Emerging Leader Prize.
Dr Axelrad has become a leader in the area of malignancy among patients with IBD, which was recognized with the Sherman Emerging Leader Prize.
Dr Axelrad has become a leader...
12/25/2024
Advances in Inflammatory Bowel Disease Network
Anthony de Buck
Conference coverage
Anthony de Buck, MD, on Positioning Surgery for Crohn's Disease
12/10/2024
Dr de Buck explains how early surgery may be an excellent option in Crohn's disease, when to provide adjuvant medical therapy, monitoring patients after procedures, and that the type of surgery is less important than the timing.
Dr de Buck explains how early surgery may be an excellent option in Crohn's disease, when to provide adjuvant medical therapy, monitoring patients after procedures, and that the type of surgery is less important than the timing.
Dr de Buck explains how early...
12/10/2024
Advances in Inflammatory Bowel Disease Network
Video
James Lewis, MD, on Diet and Nutrition in Crohn's Disease
12/09/2024
Dr James Lewis, from the University of Pennsylvania, recaps his presentation on using diet as an adjunct to medical therapy for Crohn's disease, and its potential to induce remission and even prevent IBD among those at high risk.
Dr James Lewis, from the University of Pennsylvania, recaps his presentation on using diet as an adjunct to medical therapy for Crohn's disease, and its potential to induce remission and even prevent IBD among those at high risk.
Dr James Lewis, from the...
12/09/2024
Advances in Inflammatory Bowel Disease Network
Video
Maria Abreu, MD, on When the First Advanced Therapy Fails in UC
12/09/2024
What do you do when a first advanced therapy fails to control ulcerative colitis? Dr Abreu reviews her presentation from the Advances in IBD conference on how choose the next option among the many therapies available now.
What do you do when a first advanced therapy fails to control ulcerative colitis? Dr Abreu reviews her presentation from the Advances in IBD conference on how choose the next option among the many therapies available now.
What do you do when a first...
12/09/2024
Advances in Inflammatory Bowel Disease Network

Interactive Features

medical quiz
Quiz
Surgical Outcomes for Crohn's Disease vs Ulcerative Colitis
07/14/2023
Are surgical outcomes the same for patients with Crohn's disease as they are for patients with ulcerative colitis? Find out with a quick quiz.
Are surgical outcomes the same for patients with Crohn's disease as they are for patients with ulcerative colitis? Find out with a quick quiz.
Are surgical outcomes the same...
07/14/2023
Advances in Inflammatory Bowel Disease Network
OR shot
Quiz
Colectomy Rates Among Patients With UC
02/22/2023
Recent research looked at rates of colectomy among patients with ulcerative colitis to determine if there were significant differences by race or ethnicity. See if you can guess what that study revealed by taking our quick quiz.
Recent research looked at rates of colectomy among patients with ulcerative colitis to determine if there were significant differences by race or ethnicity. See if you can guess what that study revealed by taking our quick quiz.
Recent research looked at rates...
02/22/2023
Advances in Inflammatory Bowel Disease Network
quiz
Quiz
Does Crohn's Disease or Ulcerative Colitis Present the Highest Risk of Multiple EIMs?
12/11/2023
Extraintestinal manifestations (EIMs) are seen in 25-40% of patients with inflammatory bowel disease. Take a quick quiz to find out who is more at risk of developing multiple EIMs.
Extraintestinal manifestations (EIMs) are seen in 25-40% of patients with inflammatory bowel disease. Take a quick quiz to find out who is more at risk of developing multiple EIMs.
Extraintestinal manifestations...
12/11/2023
Advances in Inflammatory Bowel Disease Network
light bulb+quiz
Quiz
Positioning Diet for Crohn's Disease
09/04/2023
David Rubin, MD, explained some key differences between the different diets in the management of Crohn's disease to achieve the best possible outcomes. Do you know what diet is the most palatable and sustainable? Take our quiz to find out!
David Rubin, MD, explained some key differences between the different diets in the management of Crohn's disease to achieve the best possible outcomes. Do you know what diet is the most palatable and sustainable? Take our quiz to find out!
David Rubin, MD, explained some...
09/04/2023
Advances in Inflammatory Bowel Disease Network
quiz
Quiz
The 3 Pillars of IBD Care
07/18/2023
Do you know the essential principles of management of inflammatory bowel disease? Take a quick quiz to find out!
Do you know the essential principles of management of inflammatory bowel disease? Take a quick quiz to find out!
Do you know the essential...
07/18/2023
Advances in Inflammatory Bowel Disease Network
medical quiz
Quiz
Surgical Outcomes for Crohn's Disease vs Ulcerative Colitis
07/14/2023
Are surgical outcomes the same for patients with Crohn's disease as they are for patients with ulcerative colitis? Find out with a quick quiz.
Are surgical outcomes the same for patients with Crohn's disease as they are for patients with ulcerative colitis? Find out with a quick quiz.
Are surgical outcomes the same...
07/14/2023
Advances in Inflammatory Bowel Disease Network
Quiz
Role of Biologic Agents in IBD
06/14/2023
Are biologic agents the ultimate answer in the treatment of intestinal inflammation? Test your knowledge here!
Are biologic agents the ultimate answer in the treatment of intestinal inflammation? Test your knowledge here!
Are biologic agents the ultimate...
06/14/2023
Advances in Inflammatory Bowel Disease Network
coffee+quiz
Quiz
Resection or Medical Therapy for Early Ileocecal Crohn Disease?
05/24/2023
Experts explored the possibility of resection for patients with Crohn disease in the early stages. What did they conclude? Take our quiz to test your knowledge!
Experts explored the possibility of resection for patients with Crohn disease in the early stages. What did they conclude? Take our quiz to test your knowledge!
Experts explored the possibility...
05/24/2023
Advances in Inflammatory Bowel Disease Network
doc writing notes
Quiz
SIBO and Crohn's Disease
04/28/2023
Is there any link between small intestinal bacterial overgrowth and clinical relapse in patients with quiescent Crohn disease? Take the test to find out!
Is there any link between small intestinal bacterial overgrowth and clinical relapse in patients with quiescent Crohn disease? Take the test to find out!
Is there any link between small...
04/28/2023
Advances in Inflammatory Bowel Disease Network
Clostridioides difficile
Quiz
Increased Risk of Clostridioides difficile Among Patients with IBD
04/01/2023
In her presentation at the virtual Advances in Inflammatory Bowel Disease meeting on April 30, Monika Fischer, MD, stated, “Individuals with IBD [inflammatory bowel disease] are at 5-fold risk of getting CDI [Clostridioides difficile], more...
In her presentation at the virtual Advances in Inflammatory Bowel Disease meeting on April 30, Monika Fischer, MD, stated, “Individuals with IBD [inflammatory bowel disease] are at 5-fold risk of getting CDI [Clostridioides difficile], more...
In her presentation at the...
04/01/2023
Advances in Inflammatory Bowel Disease Network
OR shot
Quiz
Colectomy Rates Among Patients With UC
02/22/2023
Recent research looked at rates of colectomy among patients with ulcerative colitis to determine if there were significant differences by race or ethnicity. See if you can guess what that study revealed by taking our quick quiz.
Recent research looked at rates of colectomy among patients with ulcerative colitis to determine if there were significant differences by race or ethnicity. See if you can guess what that study revealed by taking our quick quiz.
Recent research looked at rates...
02/22/2023
Advances in Inflammatory Bowel Disease Network
colonoscopy
Quiz
Endoscopic Healing in Crohn Disease
07/04/2022
A recent study compared the rates of endoscopic healing after 1 year of therapy with different classes of medications. Do you know which won out? Take our quiz to find out!
A recent study compared the rates of endoscopic healing after 1 year of therapy with different classes of medications. Do you know which won out? Take our quiz to find out!
A recent study compared the...
07/04/2022
Advances in Inflammatory Bowel Disease Network

Latest News

News
Real-World Results of First-Line Advanced Therapies for Ulcerative Proctitis
12/05/2024
This retrospective cohort study, presented at the American College of Gastroenterology scientific meeting, examined the effectiveness of advanced therapies in bionaïve patients with ulcerative proctitis.
This retrospective cohort study, presented at the American College of Gastroenterology scientific meeting, examined the effectiveness of advanced therapies in bionaïve patients with ulcerative proctitis.
This retrospective cohort study,...
12/05/2024
Advances in Inflammatory Bowel Disease Network
News
Advanced Therapies for Patients With Severe Ulcerative Colitis
12/05/2024
A new study compares the efficacy of advanced therapies with corticosteroids in hospitalized patients with acute severe ulcerative colitis as first- and second-line therapies.
A new study compares the efficacy of advanced therapies with corticosteroids in hospitalized patients with acute severe ulcerative colitis as first- and second-line therapies.
A new study compares the...
12/05/2024
Advances in Inflammatory Bowel Disease Network
News
Intestinal Ultrasound Predicts Response to Therapy in Ulcerative Colitis
11/26/2024
Intestinal ultrasound served as a surrogate for endoscopy in predicting drug-specific response within 6 weeks among patients with ulcerative colitis.
Intestinal ultrasound served as a surrogate for endoscopy in predicting drug-specific response within 6 weeks among patients with ulcerative colitis.
Intestinal ultrasound served as...
11/26/2024
Advances in Inflammatory Bowel Disease Network
News
Specific Factors Predict Rescue Therapy Response in Acute Severe Ulcerative Colitis
11/22/2024
More than 3 dozen factors are associated with response to rescue therapy in patients with acute severe ulcerative colitis, according to a systematic review.
More than 3 dozen factors are associated with response to rescue therapy in patients with acute severe ulcerative colitis, according to a systematic review.
More than 3 dozen factors are...
11/22/2024
Advances in Inflammatory Bowel Disease Network
News
Impact of Concomitant Medications on Advanced Therapies for Ulcerative Colitis
11/12/2024
Most concomitant medications do not affect the efficacy or safety of advanced therapies in ulcerative colitis clinical trials, according to a recent study.
Most concomitant medications do not affect the efficacy or safety of advanced therapies in ulcerative colitis clinical trials, according to a recent study.
Most concomitant medications do...
11/12/2024
Advances in Inflammatory Bowel Disease Network
Research Highlights
Colectomy Associated With Risk of Kidney Failure
11/09/2024
Patients undergoing colectomy may benefit from enhanced kidney function monitoring, surveillance, and timely referral to nephrology care.
Patients undergoing colectomy may benefit from enhanced kidney function monitoring, surveillance, and timely referral to nephrology care.
Patients undergoing colectomy...
11/09/2024
Advances in Inflammatory Bowel Disease Network
News
Standard Dosing of Infliximab Effective for Steroid-Refractory ASUC
10/18/2024
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
Scores Predict Corticosteroid Failure Risk in Patients With ASUC
10/03/2024
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that...
10/03/2024
Advances in Inflammatory Bowel Disease Network
FDA alert
FDA Alert
FDA Approves Guselkumab for Moderate to Severe Ulcerative Colitis
09/12/2024
Johnson & Johnson’s guselkumab is the first and only fully-human, dual-acting monoclonal antibody that blocks IL-23 and binds to CD64.
Johnson & Johnson’s guselkumab is the first and only fully-human, dual-acting monoclonal antibody that blocks IL-23 and binds to CD64.
Johnson & Johnson’s guselkumab...
09/12/2024
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib vs Tofacitinib for Clinical Remission in Ulcerative Colitis
08/09/2024
Investigators conducted a head-to-head trial of the 2 JAK inhibitors to determine which performed best in achieving steroid-free clinical remission among patients with ulcerative colitis
Investigators conducted a head-to-head trial of the 2 JAK inhibitors to determine which performed best in achieving steroid-free clinical remission among patients with ulcerative colitis
Investigators conducted a...
08/09/2024
Advances in Inflammatory Bowel Disease Network
News
FDA Expands Approval of Mirikizumab to Crohn's Disease 
01/16/2025
Among those who achieved clinical remission and endoscopic response at one year, nearly 90% of patients maintained clinical remission with 2 years of continuous treatment with mirikizumab in open-label extension
Among those who achieved clinical remission and endoscopic response at one year, nearly 90% of patients maintained clinical remission with 2 years of continuous treatment with mirikizumab in open-label extension
Among those who achieved...
01/16/2025
Advances in Inflammatory Bowel Disease Network
News
Stem Cell Therapy Shows Promise for Medically Refractory Crohn’s Disease
12/16/2024
In a systematic review, stem cell therapy demonstrated a significant advantage over placebo or no treatment in achieving clinical remission among patients with refractory Crohn's disease.
In a systematic review, stem cell therapy demonstrated a significant advantage over placebo or no treatment in achieving clinical remission among patients with refractory Crohn's disease.
In a systematic review, stem...
12/16/2024
Advances in Inflammatory Bowel Disease Network
News
Study Highlights Effectiveness of Medical Therapies for Fistulizing Crohn’s Disease
12/13/2024
A systematic review assessing pharmacologic therapies for fistulizing Crohn’s disease (CD), has provided insights into their efficacy.
A systematic review assessing pharmacologic therapies for fistulizing Crohn’s disease (CD), has provided insights into their efficacy.
A systematic review assessing...
12/13/2024
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Effective for Crohn’s Disease Regardless of Prior Biologic Failure
12/06/2024
The Janus kinase inhibitor showed definite superiority over placebo in inducing and maintaining clinical remission and endoscopic response among patients who did not respond or lost response to biologic therapies for Crohn’s disease.
The Janus kinase inhibitor showed definite superiority over placebo in inducing and maintaining clinical remission and endoscopic response among patients who did not respond or lost response to biologic therapies for Crohn’s disease.
The Janus kinase inhibitor...
12/06/2024
Advances in Inflammatory Bowel Disease Network
News
MRI and Blood Biomarkers Predict Surgery Risk in Ileal Crohn’s Disease
12/05/2024
A new study highlights the predictive power of MRI metrics and circulating biomarkers in determining surgical needs for children and adults with Crohn’s disease.
A new study highlights the predictive power of MRI metrics and circulating biomarkers in determining surgical needs for children and adults with Crohn’s disease.
A new study highlights the...
12/05/2024
Advances in Inflammatory Bowel Disease Network
News
Extraintestinal Risks in IBD: Who’s Most Vulnerable?
12/05/2024
A large cohort study reveals key factors linked to multiple extraintestinal manifestations in inflammatory bowel disease, offering new insights into personalized treatment approaches.
A large cohort study reveals key factors linked to multiple extraintestinal manifestations in inflammatory bowel disease, offering new insights into personalized treatment approaches.
A large cohort study reveals key...
12/05/2024
Advances in Inflammatory Bowel Disease Network
News
Real-World Results of First-Line Advanced Therapies for Ulcerative Proctitis
12/05/2024
This retrospective cohort study, presented at the American College of Gastroenterology scientific meeting, examined the effectiveness of advanced therapies in bionaïve patients with ulcerative proctitis.
This retrospective cohort study, presented at the American College of Gastroenterology scientific meeting, examined the effectiveness of advanced therapies in bionaïve patients with ulcerative proctitis.
This retrospective cohort study,...
12/05/2024
Advances in Inflammatory Bowel Disease Network
News
Advanced Therapies for Patients With Severe Ulcerative Colitis
12/05/2024
A new study compares the efficacy of advanced therapies with corticosteroids in hospitalized patients with acute severe ulcerative colitis as first- and second-line therapies.
A new study compares the efficacy of advanced therapies with corticosteroids in hospitalized patients with acute severe ulcerative colitis as first- and second-line therapies.
A new study compares the...
12/05/2024
Advances in Inflammatory Bowel Disease Network
News
AI Breakthrough in Crohn’s Disease: Automated Imaging Enhances Diagnosis
12/04/2024
A new deep learning model accurately identifies Crohn’s disease lesions and assesses disease activity, offering radiologists a powerful tool for precision care.
A new deep learning model accurately identifies Crohn’s disease lesions and assesses disease activity, offering radiologists a powerful tool for precision care.
A new deep learning model...
12/04/2024
Advances in Inflammatory Bowel Disease Network
News
Intestinal Ultrasound Predicts Response to Therapy in Ulcerative Colitis
11/26/2024
Intestinal ultrasound served as a surrogate for endoscopy in predicting drug-specific response within 6 weeks among patients with ulcerative colitis.
Intestinal ultrasound served as a surrogate for endoscopy in predicting drug-specific response within 6 weeks among patients with ulcerative colitis.
Intestinal ultrasound served as...
11/26/2024
Advances in Inflammatory Bowel Disease Network

Latest Podcasts

IBD Drive time logo
Podcast
IBD Drive Time: Frank Scott, MD, on the AGA Guidelines for Ulcerative Colitis Management
12/30/2024
In this IBD Drive Time podcast, Dr Frank Scott from the University of Colorado and host Dr Raymond Cross discuss updates in the AGA guidelines for ulcerative colitis.
In this IBD Drive Time podcast, Dr Frank Scott from the University of Colorado and host Dr Raymond Cross discuss updates in the AGA guidelines for ulcerative colitis.
In this IBD Drive Time podcast,...
12/30/2024
Advances in Inflammatory Bowel Disease Network
Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
10/21/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
10/21/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Erin Forster, MD, on Risankizumab for Ulcerative Colitis
09/03/2024
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical...
09/03/2024
Advances in Inflammatory Bowel Disease Network
David Hudesman
Podcast
David Hudesman, MD, on Efficacy of Tofacitinib Induction for Ulcerative Colitis
03/07/2023
Dr Hudesman reviews the findings of a post hoc analysis he and colleagues conducted to assess associations between C-reactive protein, partial Mayo score, and efficacy outcomes during tofacitinib induction.
Dr Hudesman reviews the findings of a post hoc analysis he and colleagues conducted to assess associations between C-reactive protein, partial Mayo score, and efficacy outcomes during tofacitinib induction.
Dr Hudesman reviews the findings...
03/07/2023
Advances in Inflammatory Bowel Disease Network
Bruce Sands
Podcast
Bruce Sands, MD, on the VEGA Study of Combination Biologic Therapy in UC
12/19/2022
Dr Sands provides an overview of the VEGA study, the first of its kind to combine 2 biologic agents to attempt to achieve higher rates of remission among patients with ulcerative colitis.
Dr Sands provides an overview of the VEGA study, the first of its kind to combine 2 biologic agents to attempt to achieve higher rates of remission among patients with ulcerative colitis.
Dr Sands provides an overview of...
12/19/2022
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Frank Scott, MD, on the AGA Guidelines for Ulcerative Colitis Management
12/30/2024
In this IBD Drive Time podcast, Dr Frank Scott from the University of Colorado and host Dr Raymond Cross discuss updates in the AGA guidelines for ulcerative colitis.
In this IBD Drive Time podcast, Dr Frank Scott from the University of Colorado and host Dr Raymond Cross discuss updates in the AGA guidelines for ulcerative colitis.
In this IBD Drive Time podcast,...
12/30/2024
Advances in Inflammatory Bowel Disease Network
Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
10/21/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
10/21/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Drs James Lewis and Laura Raffals on SPARC
10/21/2024
Dr Raymond Cross hosts Drs James Lewis and Laura Raffals in a discussion of SPARC, a study of adults with inflammatory bowel disease in which patients are followed prospectively to collect data about to allow prediction of disease course and...
Dr Raymond Cross hosts Drs James Lewis and Laura Raffals in a discussion of SPARC, a study of adults with inflammatory bowel disease in which patients are followed prospectively to collect data about to allow prediction of disease course and...
Dr Raymond Cross hosts Drs James...
10/21/2024
Advances in Inflammatory Bowel Disease Network
Freddy Caldera
Podcast
Freddy Caldera, DO, on the RSV Vaccine for Patients With IBD
10/11/2024
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University...
10/11/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Updates on the PIANO Study of IBD and Pregnancy
10/07/2024
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie...
10/07/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: David Hudesman, MD, on Work Productivity in IBD
09/19/2024
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone...
09/19/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Erin Forster, MD, on Risankizumab for Ulcerative Colitis
09/03/2024
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical...
09/03/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Dr Jana Al Hashash on Diet and Nutrition in IBD Care
08/05/2024
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo...
08/05/2024
Advances in Inflammatory Bowel Disease Network
Shubha Bhat
Podcast
Shubha Bhat, PharmD, on the Role of the Clinical Pharmacist in IBD
07/25/2024
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent...
07/25/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: The Best of DDW, Part 2
07/18/2024
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast,...
07/18/2024
Advances in Inflammatory Bowel Disease Network

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use